Phase Bioscience Inc., a Durham, N.C.-based developer of therapeutic fusion proteins, has raised$25 million in new Series B funding. New Enterprise Associates and a unit of OSI Pharmaceuticals were joined by return backers Hatteras Venture Partners, Johnson & Johnson Development Corp. and Fletcher Spaght Ventures. The company previously raised around $6.8 million.
3 min read · 08 January 2010
EyeGate Pharma, a Paris-based developer of iontophoresis technology to non-invasively deliver therapeutics for ocular indications, has raised $22.6 million in Series D funding (including an initial $11m calldown). Natixis Private Equity and Emerging Capital were joined by return backers Ventech, Innoven Partners and Medicis Capital. The company previously raised around $31 million.
2 min read · 08 January 2010
1 min read · 08 January 2010
Predictive Biosciences, a Lexington, Mass.-based developer of intervention diagnostic assays for cancer management, has acquired OncoDiagnostic Laboratory, an anatomic pathology and molecular diagnostics lab. No financial terms were disclosed. Predictive Biosciences has raised around $32 million in VC funding from New Enterprise Associates, Kaiser Permanente Ventures, Flybridge Capital Partners and Highland Capital Partners.
4 min read · 08 January 2010
1 min read · 08 January 2010
Discera Inc., a San Jose, Calif.-based fabless analog semiconductor company that makes miniature silicon resonators for the frequency and timing control markets, has $11 million in Series D funding. Lurie Investments was joined by return backers Scale Venture Partners, Horizon Ventures and Ardesta. The company previously had raised over $48 million from the aforementioned firms, plus from 3i Group and Partech International.
2 min read · 08 January 2010
Eisai Co. Ltd. has acquired AkaRx Inc., a Paramus, N.J.-based drug company focused on thrombocytopenia, for $255 million. AkaRx had raised over $16 million in VC funding, from InterWest Partners, Astellas Venture Capital and Sutter Hill Ventures.
1 min read · 08 January 2010
1 min read · 07 January 2010
BMC Software (Nasdaq: BMC) has acquired Phurnace Software Inc., an Austin, Texas-based Java application deployment company. No financial terms were disclosed. Phurnace raised raised around $6 million in VC funding from S3 Ventures and DFJ Mercury.
2 min read · 07 January 2010
1 min read · 07 January 2010
